Covered recipient · General Payments record
ABEERA ALI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$2,028.66
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $574.56 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $276.11 | 20 |
| PFIZER INC. | $41.02 | 2 |
| Amneal Pharmaceuticals LLC | $40.14 | 2 |
| TG THERAPEUTICS, INC. | $34.50 | 1 |
| LivaNova USA, Inc. | $31.49 | 1 |
| Teva Pharmaceuticals USA, Inc. | $27.76 | 1 |
| Biogen, Inc. | $20.59 | 1 |
| Neurocrine BioSciences, Inc. | $20.10 | 1 |
| Lilly USA, LLC | $19.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.98 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.13 | 1 |
| GE HEALTHCARE | $14.51 | 1 |
| ACADIA Pharmaceuticals Inc | $14.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.56 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202549 | CMS |
| ABBVIE INC. | $16.51 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202551 | CMS |
| ABBVIE INC. | $24.22 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202553 | CMS |
| ABBVIE INC. | $22.71 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202555 | CMS |
| ABBVIE INC. | $18.25 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202557 | CMS |
| ABBVIE INC. | $16.35 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202559 | CMS |
| ABBVIE INC. | $2.07 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202561 | CMS |
| ABBVIE INC. | $6.44 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202563 | CMS |
| ABBVIE INC. | $16.67 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202565 | CMS |
| ABBVIE INC. | $17.17 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202567 | CMS |
| ABBVIE INC. | $2.63 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202569 | CMS |
| ABBVIE INC. | $2.56 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202571 | CMS |
| ABBVIE INC. | $34.25 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202573 | CMS |
| ABBVIE INC. | $2.52 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202575 | CMS |
| ABBVIE INC. | $19.90 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202577 | CMS |
| ABBVIE INC. | $5.84 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202579 | CMS |
| ABBVIE INC. | $15.05 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202581 | CMS |
| ABBVIE INC. | $1.13 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202583 | CMS |
| ABBVIE INC. | $17.51 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202585 | CMS |
| ABBVIE INC. | $9.77 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103202587 | CMS |
| ACADIA Pharmaceuticals Inc | $14.48 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147961089 | CMS |
| Alexion Pharmaceuticals, Inc. | $16.13 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093899033 | CMS |
| Amneal Pharmaceuticals LLC | $26.98 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178563 | CMS |
| Amneal Pharmaceuticals LLC | $13.16 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178565 | CMS |
| Biogen, Inc. | $20.59 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104814487 | CMS |
| GE HEALTHCARE | $14.51 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144681722 | CMS |
| Lilly USA, LLC | $19.75 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136002977 | CMS |
| LivaNova USA, Inc. | $31.49 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798527 | CMS |
| Neurocrine Biosciences, Inc. | $20.10 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150858451 | CMS |
| Novartis Pharmaceuticals Corporation | $17.98 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086639965 | CMS |
| PFIZER INC. | $14.16 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131746110 | CMS |
| PFIZER INC. | $26.86 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130880014 | CMS |
| Teva Pharmaceuticals USA, Inc. | $27.76 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151623991 | CMS |
| TG Therapeutics, Inc. | $34.50 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136870128 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.